Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed May 15, 2025 · 10-Q · 45 days after period end · 0001280776-25-000008
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$25.47M | -$29.58M | -$25.27M | -$20.81M |
| EPS Diluted | -$2.51 | -$0.30 | -$0.58 | -$0.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end
